M y colleagues and I have been calling for a fundamental shift in how the biologicals industry screens for microbes. Microbial product performance remains inconsistent because the indus try has been screening for func tion alone, and that will never be enough to deliver what farmers need from biological products. A microbe must colonize and persist in a soil community that is already there. That’s what farmers need, especially as markets and weather grow more volatile. The ques-tion is whether a product wins often enough, across enough variation, that a farmer can rely on it and a partner can build a program on it. Jord recently launched 9311, our first commercially available bios timulant for soy-beans and winner of the 2026 “Biological Crop Input Solution of the Year” award. It is built on microbial activator technology, which evaluates microbes for their ability to colonize a root, persist through a season, activate other beneficial microbes and func-tion alongside everything already in the field. Across three years of soybean field trials, 9311 delivered a 2.6-bushel-per-acre average yield advantage over elite industry- standard seed treatments and biologicals, with a 79 percent win rate, where a win is greater than 0.5 bushel per acre. Tri als also measured a 30 percent increase in early-season biomass over an elite commercial treatment base. Those trials spanned low-, medium- and high- yield environments across dry, wet and mixed conditions. Commercial trials in 2026 are showing similar results in emergence and vigor, with prom ising increases in nodulation. We screened these microbes not only for what they do, but also for how they fit into re-al-world soil and cropping systems, and how they activate other beneficial microbes. We hold our products to the standard that microbial activator technology sets, drawn from a proprietary collection of more than 6,500 isolates curated over three decades. That’s a higher bar, and it eliminates candidates that look excellent in the lab but fail in the field. It’s why 9311’s results have held across four years of variable condi tions. This was designed, not discovered at random. 9311 is our first public proof that the process works, and we’re offering partners a full discovery ap proach they can apply to their own pipelines. Farmers deserve tools that work acre after acre, season after sea son. That has always been our standard. 9311 clears it, and it will not be the last. If you’re building a biological program, we’re ready to partner. Farmers deserve tools that work acre after acre,season after season. BIOLOGICALS Dr. Keri Carstens President and CEO, Jord BioScience DECEMBER 2026 SEEDWORLD.COM / 37
View this content as a flipbook by clicking here.